WTO IP rights: The future of products combating COVID-19

The Biden Administration recently announced that it would support the request for a World Trade Organization (WTO) waiver of intellectual property (IP) rights under the WTO Agreement on...

Buy American panel discussion: How will this month's Executive Order impact drug and device companies, and what should you do about it?

On August 6, 2020, U.S. President Donald Trump issued his much-anticipated "Buy American" Executive Order (EO), aimed at shoring up domestic manufacture of "essential medicines", "medical...

FDLI Annual Conference: Exploring Advanced Topics in Food and Drug Law

Philip Katz and Brian D. Eyink presented at the Food and Drug Law Institute (FDLI) Annual Conference, which addresses complex legal, regulatory, compliance, and policy issues in all facets...

The Orphan Drug Act: New challenges and new opportunities

On November 28, 2018, Philip Katz and George A. O'Brien presented a complimentary webinar to discuss

27th Annual ROTH Conference

Hogan Lovells is pleased to be sponsoring the 27th Annual ROTH Conference taking place 8-11 March 2015 in Dana Point, California. Hosted by ROTH Capital Partners, this event draws over 500...

International Pharmaceutical Regulatory and Compliance Congress and Best Practices Forum

Hogan Lovells is a sponsor of the PCF International Pharma Congress, which brings together senior global compliance professionals and legal counsel from around the world to share...

Loading data